According to the Centers for Disease Control, age related macular degeneration (AMD) is a major cause of blindness worldwide and is the leading cause of vision loss and blindness for Americans aged 65 years and older.
In this case study, a global top 10 pharma company wanted to build relationships with key healthcare professionals (HCPs) who specialize in AMD; to expand its scientific share of voice and to reach new treatment leaders and digital influencers for a U.S. based medical science liaison team.
Using the H1 platform, they found evolving demographics and dynamics of experts that specialize in AMD and opportunities to diversify their pool of medical thought leaders and reach previously untouched or unknown treatment leaders.
H1’s analysis also uncovered opportunities to engage with KOLs in expanded digital channels like Twitter and LinkedIn.
Get the case study below: